Showing results (61-70 of 177) with videos related to
Sort By:
Pageof 18
Bioinformatics (Oxford, England)|February 25, 2026
CERTOMICS: Trusted Single-Cell Multiomics Pipeline for High-Resolution Profiling of Adoptive Cellular ImmunotherapiesChristina Katharina Kuhn, David Schmidt, Michael Rade, et al.Oncology|October 3, 2024
Efficacy and Safety of Autologous Stem Cell Transplantation in First-Line Treatment and at Relapse in Elderly Patients with Multiple MyelomaEva-Maria Klein, Sejla Hujic, Kaya Miah, et al.Transplantation and Cellular Therapy|August 5, 2024
Allogeneic Hematopoietic Cell Transplantation for Myelofibrosis Aged 70 Years or Older: A Study from the German Registry for Stem Cell TransplantationNico Gagelmann, Claudia Schuh, Robert Zeiser, et al.Hemasphere|January 17, 2025
Idecabtagene vicleucel or ciltacabtagene autoleucel for relapsed or refractory multiple myeloma: An international multicenter studyMaximilian Merz, Anca-Maria Albici, Bastian von Tresckow, et al.Nature Communications|January 20, 2025
Reconstructing skeletal homeostasis through allogeneic hematopoietic stem cell transplantation in myelofibrosisMathias Schäfersküpper, Alexander Simon, Timur A Yorgan, et al.Blood|February 15, 2019
Comprehensive clinical-molecular transplant scoring system for myelofibrosis undergoing stem cell transplantationNico Gagelmann, Markus Ditschkowski, Rashit Bogdanov, et al.Rheumatology (Oxford, England)|April 23, 2025
A novel approach to refractory idiopathic inflammatory myopathy: CD19 CAR T-cell therapy-case report and literature reviewIsabell Haase, Johanna Richter, Marie-Therese Holzer, et al.American Journal of Hematology|August 11, 2016
Baseline characteristics, chromosomal alterations, and treatment affecting prognosis of deletion 17p in newly diagnosed myelomaMaximilian Merz, Thomas Hielscher, Anja Seckinger, et al.Hematological Oncology|March 21, 2017
Bortezomib-induced peripheral neuropathy: A genome-wide association study on multiple myeloma patientsChiara Campo, Miguel Inacio da Silva Filho, Niels Weinhold, et al.American Journal of Hematology|May 14, 2024
Impact of busulfan versus treosulfan dose intensity in myelofibrosis undergoing hematopoietic cell transplantationNico Gagelmann, Claudia Schuh, Sarah Flossdorf, et al.Pageof 18